Killing kinetics of meropenem against penicillin-resistant pneumococci

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Pneumococcal infections pose a significant public health challenge, particularly those caused by multidrug-resistant strains.
• Penicillin resistance in Streptococcus pneumoniae necessitates the exploration of alternative antimicrobial agents.

Purpose of the Study:

• To evaluate the killing kinetics of meropenem against clinical isolates of Streptococcus pneumoniae with varying penicillin susceptibility.
• To determine the bactericidal activity of meropenem at different concentrations relative to the minimum inhibitory concentration (MIC).

Main Methods:

• Studied killing kinetics of meropenem against 16 clinical pneumococcal isolates (12 penicillin-resistant, 3 intermediate, 1 sensitive).
• Meropenem was tested at 1x, 2x, and 4x the MIC for each isolate.
• Bactericidal activity was assessed by monitoring the reduction in colony-forming units (cfu/mL).

Main Results:

• Meropenem exhibited rapid bactericidal activity against most pneumococcal strains tested.
• Killing exceeding 3 log10 cfu/mL was achieved for nine out of sixteen isolates.
• The carbapenem demonstrated potent activity even against penicillin-resistant pneumococci.

Conclusions:

• Meropenem displays significant bactericidal efficacy against multidrug-resistant pneumococci.
• This antimicrobial strategy warrants clinical evaluation as a potential alternative for treating mixed infections.
• Meropenem could be a valuable option for infections involving resistant Streptococcus pneumoniae.